Allergan, Inc. et al v. Revance Therapeutics, Inc. et al
| Allergan, Inc., Allergan Pharmaceuticals Ireland and Allergan USA, Inc. |
| Revance Therapeutics, Inc. and Ajinomoto Althea, Inc. doing business as Ajinomoto Bio-Pharma Services |
| 1:2021cv01411 |
| October 1, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent |
| 35 U.S.C. § 271 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 17, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Pro Hac Vice Attorney Ryan E. Conkin, Adam C. LaRock, and Dennies Varughese for Ajinomoto Althea, Inc., and Revance Therapeutics, Inc added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (smg) Modified on 11/29/2021 (smg).
|
|
Filing 18
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan USA, Inc. filed by Allergan Pharmaceuticals Ireland, Allergan USA, Inc., Allergan, Inc.. (Blumenfeld, Jack)
|
|
Filing 17
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,332,567 ;7,354,740 ;8,409,828 ;11,033,625 ;11,124,786 ;11,147,878 . (Blumenfeld, Jack)
|
|
Filing 16
First Amended Complaint for Patent Infringement against Ajinomoto Althea, Inc., Revance Therapeutics, Inc. - filed by Allergan, Inc., Allergan Pharmaceuticals Ireland, Allergan USA, Inc.. (Attachments: #1 Exhibits 1-36)(Blumenfeld, Jack) Modified on 11/29/2021 (nms).
|
|
Filing 15
STIPULATION and Proposed Order to Extend Time - filed by Allergan Pharmaceuticals Ireland, Allergan, Inc.. (Blumenfeld, Jack) Modified on 11/15/2021 (nms).
|
|
SO ORDERED, re #15 STIPULATION and Proposed Order to Extend Time(*Reset Briefing Schedule: re #10 MOTION to Dismiss. Answering Brief due 12/1/2021). Signed by Judge Richard G. Andrews on 11/15/2021. (nms)
|
|
Filing 14
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Revance Therapeutics, Inc.. (Wilson, Samantha)
|
|
Filing 13
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ajinomoto Co., Inc. for Ajinomoto Althea, Inc. filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha)
|
|
SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm. D., Eldora L. Ellison, Ph.D., Adam C. LaRock, Olga A. Partington, Ph.D., and Ryan E. Conkin, filed by Revance Therapeutics, Inc., Ajinomoto Althea, Inc.. Signed by Judge Richard G. Andrews on 11/4/2021. (nms)
|
|
Filing 12
MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm. D., Eldora L. Ellison, Ph.D., Adam C. LaRock, Olga A. Partington, Ph.D., and Ryan E. Conkin - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha)
|
|
Filing 11
OPENING BRIEF in Support re #10 MOTION to Dismiss, filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..Answering Brief/Response due date per Local Rules is 11/17/2021. (Gaza, Anne) Modified on 11/4/2021 (nms).
|
|
Filing 10
MOTION to Dismiss - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: #1 Proposed Order)(Gaza, Anne) Modified on 11/4/2021 (nms).
|
|
SO ORDERED, re #9 STIPULATION and Proposed Order to Extend Time to move against, answer, or otherwise respond to the Complaint (*Reset Answer Deadlines: Ajinomoto Althea, Inc. answer due 11/24/2021; Revance Therapeutics, Inc. answer due 11/24/2021). Signed by Judge Richard G. Andrews on 10/19/2021. (nms)
|
|
Filing 9
STIPULATION TO EXTEND TIME for Defendants to move against, answer, or otherwise respond to the Complaint for Patent Infringement to November 24, 2021 - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Gaza, Anne)
|
|
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
|
|
Filing 8
SUMMONS Returned Executed by Allergan, Inc., Allergan Pharmaceuticals Ireland. Ajinomoto Althea, Inc. served on 10/4/2021, answer due 10/25/2021. (Dellinger, Megan)
|
|
Filing 7
SUMMONS Returned Executed by Allergan, Inc., Allergan Pharmaceuticals Ireland. Revance Therapeutics, Inc. served on 10/4/2021, answer due 10/25/2021. (Dellinger, Megan)
|
|
Filing 6
Summons Issued with Magistrate Consent Notice attached as to Revance Therapeutics, Inc. on 10/4/2021. (twk)
|
|
Filing 5
Summons Issued with Magistrate Consent Notice attached as to Ajinomoto Althea, Inc. on 10/4/2021. (twk)
|
|
Filing 4
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan Pharmaceuticals Ireland, Allergan, Inc. filed by Allergan Pharmaceuticals Ireland, Allergan, Inc.. (twk)
|
|
Filing 3
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,332,567 B2; 7,354,740 B2; 8,409,828 B2; 11,033,625 B2; 11,124,786 B2. (twk)
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk)
|
|
Filing 1
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Ajinomoto Althea, Inc., Revance Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3712877.) - filed by Allergan, Inc., Allergan Pharmaceuticals Ireland. (Attachments: #1 Exhibit 1-26, #2 Civil Cover Sheet)(twk)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
